Saltar al contenido
Merck

Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells.

The American journal of Chinese medicine (2015-02-03)
Byul-Bora Choi, Jeong Hae Choi, Sang-Rye Park, Ji-Young Kim, Jin-Woo Hong, Gyoo-Cheon Kim
RESUMEN

Scutellariae radix is one of the most widely used anticancer herbal medicines in several Asian countries, including Korea, Japan, and China. Squamous cell carcinoma (SCC) is one of the most common head and neck carcinomas, which is highly invasive and metastatic, and can potentially develop chemoresistance. Therefore, new effective treatment methods are urgently needed. We determined the effects of Scutellariae radix on SCC-25 cells using the WST-1 assay, F-actin staining, flow cytometry analysis, immunofluorescence staining, and western blot analysis. Scutellariae radix treatment inhibited SCC-25 cell growth in a dose- and time-dependent manner, but it did not inhibit HaCaT (human keratinocyte) cell growth. Changes in cell morphology and disruption of filamentous (F)-actin organization were observed. Scutellariae radix-induced apoptosis as indicated by the translocation of cytochrome c and apoptosis-inducing factor (AIF) into the nucleus and cytosol. Scutellariae radix-induced an increase in cells with sub-G1 DNA content, and increased Bax, cleaved caspase-3, caspase-7, caspase-9, DNA fragmentation factor 45 (DFF 45), and poly(ADP-ribose) polymerase-1 (PARP-1) expression levels. Furthermore, increased expression of phosphorylated mitogen-activated protein kinase (MAPK)-related proteins was detected. The antitumor effect of Scutellariae radix was due to decreased cell proliferation, changes in cell morphology, and the activation of caspase and MAPK pathways. Taken together, the findings of this study highlight the anticancer activity of Scutellariae radix in chemoresistant SCC-25 oral squamous carcinoma cells.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Dimetilsulfóxido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, Molecular Biology
Sigma-Aldrich
Dimetilsulfóxido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimetilsulfóxido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Yoduro de propidio, ≥94.0% (HPLC)
Sigma-Aldrich
Fluoruro de fenilmetansulfonilo, ≥98.5% (GC)
Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
Dimetilsulfóxido, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Fluoruro de fenilmetansulfonilo, ≥99.0% (T)
Sigma-Aldrich
Etoposide, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
Dimetilsulfóxido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Propidium iodide solution
Sigma-Aldrich
Dimetilsulfóxido, PCR Reagent
Sigma-Aldrich
Yoduro de propidio, ≥94% (HPLC)
Sigma-Aldrich
DL-Glyceraldehyde 3-phosphate solution, 45-55 mg/mL in H2O
Supelco
Dimetilsulfóxido, analytical standard
Supelco
Dimetilsulfóxido, for inorganic trace analysis, ≥99.99995% (metals basis)
USP
Dimetilsulfóxido, United States Pharmacopeia (USP) Reference Standard
Supelco
5-Fluorouracil, analytical standard
Supelco
Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Fluorouracil, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
Etoposide, European Pharmacopoeia (EP) Reference Standard
Dimetilsulfóxido, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Fluorouracil, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dimetilsulfóxido, ≥99.6%, ReagentPlus®